Data protection Impressum

R&D

The Swiss Scale-Up Report 2026, the first benchmark of Switzerland's growth-stage companies, identifies 265 scale-ups with a combined estimated valuation of CHF 26.6 billion. Vaud ranks second among cantons, and EPFL stands alongside ETH Zurich as a leading source of spin-offs.

Business environment

First Swiss Scale-Up Report maps 265 growth companies, with Western Switzerland among the leading hubs

22 September 2026

Corintis has taken first place in the Top100 Swiss Startup Ranking 2026, ahead of Zurich's DeepJudge and Villeneuve-based PAVE Space. Five of the ten highest-ranked companies are based in Western Switzerland.

Corintis tops the Top100 Swiss Startup Ranking 2026, with half the top ten from Western Switzerland

14 September 2026

The tenth Swiss Medtech Industry Study reports a sector generating CHF 26 billion in sales and growing at twice the rate of the Swiss economy, while flagging a marked slowdown in job creation and investment. Western Switzerland accounts for a substantial share of the country's medtech base.

Swiss medtech grows twice as fast as the economy

14 September 2026

The Empa campus in Thun has split its Advanced Materials Processing laboratory into two independent units dedicated to surfaces and interfaces on one side and to metallic materials and manufacturing on the other, as researchers on the site make computational tools for alloy design accessible through a conversational AI agent.

Empa in Thun splits into two labs for materials and metals

7 September 2026

FluoSphera, the Geneva-based biotech developing advanced in vitro models, has entered a license agreement for Debiopharm's AbYlink antibody conjugation technology, combining it with light sheet microscopy from Leica Microsystems into a single workflow for antibody characterization.

FluoSphera partners with Debiopharm and Leica Microsystems

7 September 2026

An interdisciplinary team from the University of Bern and Inselspital has developed CARESCORE, an AI model that calculates a patient's individual risk of postoperative infection within seconds of surgery ending, by drawing on vital signs recorded during the procedure.

Bern researchers develop an AI model that predicts infection risk at the end of surgery

31 August 2026

Building on its pilot plant in the Neuchâtel mountains, Sun-Ways has signed an agreement with its first commercial partner in Italy, entered a technology agreement with France's SNCF and received government approval for a first project in South Korea.

Sun-Ways takes its rail-mounted solar technology to Italy, France and South Korea

31 August 2026

The canton of Fribourg has officially handed over to the Confederation the keys to Agroscope's new laboratory building in Posieux, a CHF 125 million facility that forms the centerpiece of the national agricultural research center's site strategy.

Agroscope opens its new CHF 125 million laboratory in Fribourg

20 August 2026

Spineart, the Geneva-based medtech company specializing in spine surgery, has received FDA approval for its BAGUERA C cervical disc for one and two contiguous levels, expanding access in the United States to a motion-preserving solution for cervical disc disease.

Spineart receives FDA approval for its BAGUERA C cervical disc

20 August 2026

A new study conducted at Bern’s University Hospital shows that VisionOne, the virtual reality eye-testing platform developed by Vaud-based PeriVision, delivers clinical performance comparable to the stationary perimeter considered the gold standard, including in advanced glaucoma.

PeriVision’s VR eye test matches the gold standard across glaucoma severity

17 August 2026

1 2 3 4 5 … 17